The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Recurrence and Survival Outcomes After Anatomic Segmentectomy Versus Lobectomy for Clinical Stage I Non–Small-Cell Lung Cancer: A Propensity-Matched Analysis
Open accessAbstract
Purpose: Although anatomic segmentectomy has been considered a compromised procedure by many surgeons, recent retrospective, single-institution series have demonstrated tumor recurrence and patient survival rates that approximate those achieved by lobectomy. The primary objective of this study was to use propensity score matching to compare outcomes after these anatomic resection approaches for stage I non–small-cell lung cancer. Patients and Methods: A retrospective data set including 392 segmentectomy patients and 800 lobectomy patients was used to identify matched segmentectomy and lobectomy cohorts (n = 312 patients per group) using a propensity score matching algorithm that accounted for confounding effects of preoperative patient variables. Primary outcome variables included freedom from recurrence and overall survival. Factors affecting survival were assessed by Cox regression analysis and Kaplan-Meier estimates. Results: Perioperative mortality was 1.2% in the segmentectomy group and 2.5% in the lobectomy group (P = .38). At a mean follow-up of 5.4 years, comparing segmentectomy with lobectomy, no differences were noted in locoregional (5.5% v 5.1%, respectively; P = 1.00), distant (14.8% v 11.6%, respectively; P = .29), or overall recurrence rates (20.2% v 16.7%, respectively; P = .30). Furthermore, when comparing segmentectomy with lobectomy, no significant differences were noted in 5-year freedom from recurrence (70% v 71%, respectively; P = .467) or 5-year survival (54% v 60%, respectively; P = .258). Segmentectomy was not found to be an independent predictor of recurrence (hazard ratio, 1.11; 95% CI, 0.87 to 1.40) or overall survival (hazard ratio, 1.17; 95% CI, 0.89 to 1.52). Conclusion: In this large propensity-matched comparison, lobectomy was associated with modestly increased freedom from recurrence and overall survival, but the differences were not statistically significant. These results will need further validation by prospective, randomized trials (eg, Cancer and Leukemia Group B 140503 trial).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Propensity Score-Matching Methods for Nonexperimental Causal Studies
Dehejia, R. H., & Wahba, S. (2002) · Review of Economics and Statistics · doi:10.1162/003465302317331982 · Cited by 4,846
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Ginsberg, R. J., & Rubinstein, L. V. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00537-u · Cited by 3,006
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060476 · Cited by 1,706
Timmerman, R., McGarry, R., Yiannoutsos, C., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5937 · Cited by 1,556
A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003
Austin, P. C. (2008) · Statistics in Medicine · doi:10.1002/sim.3150 · Cited by 1,249
Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., 五味, 光., Niibe, Y., Karasawa, K., Hayakawa, K., Takai, Y., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318074de34 · Cited by 989
Mass screening for lung cancer with mobile spiral computed tomography scanner
Sone, S., Takashima, S., Li, F., Yang, Z., Honda, T., Maruyama, Y., Hasegawa, M., Yamanda, T., Kubo, K., Hanamura, K., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08229-9 · Cited by 931
Fakiris, A. J., McGarry, R. C., Yiannoutsos, C. T., Papiez, L., Williams, M., Henderson, M. A., & Timmerman, R. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.11.042 · Cited by 838
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study
Okada, M., Koike, T., Higashiyama, M., Yamato, Y., Kodama, K., & Tsubota, N. (2006) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.02.063 · Cited by 713
Litière, S., Werutsky, G., Fentiman, I. S., Rutgers, E., Christiaens, M.-R., Van Limbergen, E., Baaijens, M. H., Bogaerts, J., & Bartelink, H. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70042-6 · Cited by 551
Too Much Ado about Propensity Score Models? Comparing Methods of Propensity Score Matching
Baser, O. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00130.x · Cited by 372
El-Sherif, A., Gooding, W. E., Santos, R., Pettiford, B., Ferson, P. F., Fernando, H. C., Urda, S. J., Luketich, J. D., & Landreneau, R. J. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.02.029 · Cited by 354
Self-citationWarren, W. H., & Faber, L. P. (1994) · PubMed · Cited by 284
Segmental resection for lung cancer
Jensik, R. J., Faber, L. P., Milloy, F. J., & Monson, D. O. (1973) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)40590-4 · Cited by 281
Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma
Warren, W. H., & Faber, L. P. (1994) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(12)70385-9 · Cited by 255
Sawabata, N., Ohta, M., Matsumura, A., Nakagawa, K., Hirano, H., Maeda, H., & Matsuda, H. (2004) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)01511-x · Cited by 249
Image-guided Thermal Ablation of Lung Malignancies
Dupuy, D. E. (2011) · Radiology · doi:10.1148/radiol.11091126 · Cited by 170
Ong, C. L., Palma, D. A., Verbakel, W. F. A. R., Slotman, B. J., & Senan, S. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.10.003 · Cited by 136
The Society of Thoracic Surgeons National Database status report
Clark, R. E. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90359-x · Cited by 72
Paik, P. K., Johnson, M. L., D’Angelo, S. P., Sima, C. S., Ang, D. C., Doğan, S., Miller, V. A., Ladanyi, M., Kris, M. G., & Riely, G. J. (2012) · Cancer · doi:10.1002/cncr.27637 · Cited by 63
Personalized Treatment of Lung Cancer
Salgia, R., Hensing, T. A., Campbell, N. P., Salama, A. K. S., Maitland, M. L., Hoffman, P. C., Villaflor, V. M., & Vokes, E. E. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.012 · Cited by 46
Guerra, J. L. L., Gomez, D. R., Zhuang, Y., Levy, L. B., Eapen, G. A., Liu, H., Mohan, R., Komaki, R. U., Cox, J. D., & Liao, Z. X. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.065 · Cited by 46
Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges
Langer, C. J. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.09.004 · Cited by 25
Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer
Kim, D. W. N., Nam, T., Choe, K. S., & Choy, H. (2012) · Cancer Research and Treatment · doi:10.4143/crt.2012.44.2.74 · Cited by 11
Cited by
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Altorki, N., Wang, X., Kozono, D., Watt, C., Landrenau, R., Wigle, D., Port, J., Jones, D. R., Conti, M., Ashrafi, A. S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212083 · Cited by 1,106
Callister, M. E. J., Baldwin, D. R., Akram, A. R., Barnard, S., Cane, P., Draffan, J., Franks, K., Gleeson, F., Graham, R., Malhotra, P., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207168 · Cited by 958
Eguchi, T., Kameda, K., Lu, S., Bott, M. J., Tan, K. S., Montecalvo, J., Chang, J. C., Rekhtman, N., Jones, D. R., Travis, W. D., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.005 · Cited by 300
Metadata
- Authors
- Landreneau, R. J., Normolle, D. P., Christie, N. A., Awais, O., Wizorek, J. J., Abbas, G., Pennathur, A., Shende, M., Weksler, B., Luketich, J. D., & Schuchert, M. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-08-10
- Volume
- 32
- Issue
- 23
- Pages
- 2449-2455
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129836317
- Cited by
- 272
- References
- 25
- FWCI
- 15.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.